Market Place
Sourcing Support
Allena Pharma Announces New Meeting Date and New Record Date
12 Jul 2022 //
GLOBENEWSWIRE
Allena Pharma Reschedules Special Meeting to Approve Reverse Stock Split
05 Jul 2022 //
GLOBENEWSWIRE
Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering
04 May 2022 //
GLOBENEWSWIRE
Allena Receives FTD from FDA for ALLN-346 in Hyperuricemia
03 Nov 2021 //
GLOBENEWSWIRE
Allena Commences Dosing of Gout Patients in Second Phase 2a Trial of ALLN-346
29 Sep 2021 //
GLOBENEWSWIRE
Allena Pharmaceuticals Announces $28M Registered Direct Offering
13 Jul 2021 //
GLOBENEWSWIRE
Allena Pharmaceuticals Provides Update on Clinical Development Programs
12 Jul 2021 //
GLOBENEWSWIRE
Allena Pharma to Present at the Ladenburg Thalmann 2021 Virtual Conference
08 Jul 2021 //
GLOBENEWSWIRE
Allena Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
07 Jul 2021 //
GLOBENEWSWIRE
Allena Pharma to Host KOL Webinar Focused on ALLN-346
08 Jun 2021 //
GLOBENEWSWIRE
Allena Increases Previously Announced Bought Deal to $13.0 M
01 Dec 2020 //
GLOBENEWSWIRE
Allena Pharmaceuticals Announces Initial Data from Phase 1 Trial of ALLN-346
30 Nov 2020 //
STREETINSIDER
Allena Pharma rallies on convertible debt funding
30 Sep 2020 //
SEEKING ALPHA
Allena Pharmaceuticals Announces $5.0 Million Bought Deal Offering
27 Jul 2020 //
GLOBENEWSWIRE
Allena Pharmaceuticals Announces Streamlined Design for URIROX-2
12 Feb 2020 //
GLOBE NEWSWIRE
Allena Pharmaceuticals Provides Updates on Reloxaliase Development Program
04 Dec 2019 //
GLOBE NEWSWIRE
Allena`s completes enrollment in late-stage study of reloxaliase
16 Sep 2019 //
SEEKINGAPLHA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.